Showing 1,421 - 1,440 results of 1,890 for search '"type 2 diabetes"', query time: 0.10s Refine Results
  1. 1421

    Multiple Factors Related to the Secretion of Glucagon-Like Peptide-1 by XingChun Wang, Huan Liu, Jiaqi Chen, Yan Li, Shen Qu

    Published 2015-01-01
    “…Thus, glucagon-like peptide-1-based therapies (glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors) are now well accepted in the management of type 2 diabetes. The levels of glucagon-like peptide-1 are influenced by multiple factors including a variety of nutrients. …”
    Get full text
    Article
  2. 1422

    Prevalence of Metabolic Syndrome in Patients with Psoriasis by Ilkin Zindancı, Ozlem Albayrak, Mukaddes Kavala, Emek Kocaturk, Burce Can, Sibel Sudogan, Melek Koç

    Published 2012-01-01
    “…It is thought that chronic inflammation results in metabolic diseases and proinflammatory cytokines give rise to the development of atherogenesis, peripheral insulin resistance, hypertension, and type 2 diabetes. Our aim was to investigate the prevalence of metabolic syndrome in patients with psoriasis vulgaris. …”
    Get full text
    Article
  3. 1423

    Pseudomonas mendocina bacteraemia secondary to cellulitis – a report and brief series of cases by Jorge Reis, Francisca Carmo, Inês Soares, Catarina Salvado, Mariana Fidalgo

    Published 2025-01-01
    “…Case description: An 86-year-old Caucasian male, with several vascular risk factors (type 2 diabetes, hypertension, dyslipidaemia, coronary heart disease and heart failure), who presented long-standing lower limb phlyctens for which he was being treated, developed lower limb cellulitis. …”
    Get full text
    Article
  4. 1424

    Potent Oral Hypoglycemic Agents for Microvascular Complication: Sodium-Glucose Cotransporter 2 Inhibitors for Diabetic Retinopathy by Eun Hyung Cho, Se-Jun Park, Seongwook Han, Ji Hun Song, Kihwang Lee, Yoo-Ri Chung

    Published 2018-01-01
    “…The purpose of this study was to investigate the effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on the progression of diabetic retinopathy (DR) in patients with type 2 diabetes. The medical records of 21 type 2 diabetic patients who used a SGLT2i and 71 patients with sulfonylurea (control) were reviewed retrospectively. …”
    Get full text
    Article
  5. 1425

    Association of Urinary Phthalates with Self-Reported Eye Affliction/Retinopathy in Individuals with Diabetes: National Health and Nutrition Examination Survey, 2001–2010 by Manju Mamtani, Joanne E. Curran, John Blangero, Hemant Kulkarni

    Published 2016-01-01
    “…An epidemiological association between exposure to phthalates and type 2 diabetes (T2D) is known. However, the potential role of environmental phthalates in the complications of T2D is unknown. …”
    Get full text
    Article
  6. 1426

    Efficacy and Safety of Sitagliptin for the Treatment of New-Onset Diabetes after Renal Transplantation by Brian P. Boerner, Clifford D. Miles, Vijay Shivaswamy

    Published 2014-01-01
    “…Though metformin is the first-line agent for the treatment of type 2 diabetes, in renal transplant recipients, metformin is frequently avoided due to concerns about renal dysfunction and risk for lactic acidosis. …”
    Get full text
    Article
  7. 1427
  8. 1428

    Association of the Cardioankle Vascular Index and Ankle-Brachial Index with Carotid Artery Intima Media Thickness in Hemodialysis Patients by Tomohito Gohda, Hiromichi Gotoh, Yoshikazu Gotoh, Saori Yamaguchi, Yasuhiko Tomino

    Published 2013-01-01
    “…The objectives of the present study are (1) to compare the cardioankle vascular index (CAVI), ankle-brachial index (ABI), and carotid artery intima-media thickness (CA-IMT) between HD patients with and without type 2 diabetes (T2D) or prevalence of cardiovascular (CV) disease and (2) also to evaluate the relationship of these indices with CA-IMT in these patients according to ABI levels. …”
    Get full text
    Article
  9. 1429

    Factors Attributable to Cardiovascular Diseases in the Elderly Population of the Campo Alegre Resettlement, Tierralta, Córdoba by Carolina Castellanos Ramos, Brayan Domínguez Lozano, Daniela Jiménez Cordero, José Rocha Barraza

    Published 2022-09-01
    “…The variables studied were: age and sex, marital status, socioeconomic status, educational level, work status, household or personal income, health history and healthy lifestyle conditions such as high blood pressure, type 2 diabetes mellitus, physical activity , healthy eating and daily food ration, weight control, drug dependence, medical control and hypercholesterolemia. …”
    Get full text
    Article
  10. 1430

    Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance by Krzysztof Kurek, Agnieszka Mikłosz, Bartłomiej Łukaszuk, Adrian Chabowski, Jan Górski, Małgorzata Żendzian-Piotrowska

    Published 2015-01-01
    “…In the present research we evaluated the effects of myriocin application on type 2 diabetes mellitus in three different types of skeletal muscles: (1) slow-oxidative (red gastrocnemius), (2) oxidative-glycolytic (soleus), and (3) glycolytic (white gastrocnemius). …”
    Get full text
    Article
  11. 1431

    Integrated care teams in primary care improve clinical outcomes and care processes in patients with non-communicable diseases by Pei Lin Hu, Cynthia Yan-Ling Tan, Ngoc Hoang Long Nguyen, Rebekah Ryanne Wu, Juliana Bahadin, Nivedita Vikas Nadkarni, Ngiap Chuan Tan

    Published 2023-07-01
    “…The study population had hypertension, and/or hyperlipidaemia and/or type 2 diabetes mellitus (T2DM). Clinical outcomes included the proportion of patients (ICT vs. …”
    Get full text
    Article
  12. 1432

    Correlates for the severity of suicidal risk in participants with common mental disorders with comorbid chronic medical conditions in rural primary healthcare settings in India by Johnson-Pradeep Ruben, Maria L. Ekstrand, Elsa Heylen, Krishnamachari Srinivasan

    Published 2023-06-01
    “…Study eligibility criteria included being ≥30 years with at least mild depression or generalized anxiety disorder and at least one medical condition (cardiovascular disorder or type 2 diabetes mellitus). Methods and Material: The severity of suicidal risk at baseline was assessed using the Mini International Neuropsychiatric Interview (MINI), and other measures included the severity of depression (Patient Health Questionnaire-9-items (PHQ-9)), the severity of anxiety (Generalized Anxiety Disorder Scale-7-items (GAD-7)), disability, social support, quality of life, number of comorbid chronic medical illnesses, and body mass index (BMI). …”
    Get full text
    Article
  13. 1433

    Tracheal perforation and subcutaneous emphysema secondary to pseudomembranous invasive Aspergillus tracheobronchitis successfully managed with endotracheal tube manipulation by Kazushige Shiraishi, Takkin Lo

    Published 2025-01-01
    “…Case description: A 64-year-old male with type 2 diabetes mellitus presented with generalized weakness and abdominal discomfort, later diagnosed with a perforated cecum requiring right colectomy. …”
    Get full text
    Article
  14. 1434

    Cognitive dysfunction in diabetes – the ‘forgotten’ diabetes complication: a narrative review by Åke Sjöholm, Louise Bennet, Peter M. Nilsson

    Published 2025-01-01
    “…An important task for primary health care, where most patients with type 2 diabetes are diagnosed, treated, and followed, is to increase awareness and early detection of cognitive dysfunction in these patients for optimizing risk factor control.…”
    Get full text
    Article
  15. 1435

    Rectal Application of Ozone to Patients with Diabetes Mellitus by Omar Morejón Barroso, Imandra María García Menéndez, Leticia Varela Castro, Ernesto Julio Bernal Valladares

    Published 2023-02-01
    “…<br /><strong>Results:</strong> patients with type 2 diabetes mellitus predominated with 95.0 %. There was a 2,769 mmol/L decrease in blood glucose levels after treatment with rectal ozone, which shows metabolic control. …”
    Get full text
    Article
  16. 1436

    A mechanism-informed deep neural network enables prioritization of regulators that drive cell state transitions by Xi Xi, Jiaqi Li, Jinmeng Jia, Qiuchen Meng, Chen Li, Xiaowo Wang, Lei Wei, Xuegong Zhang

    Published 2025-02-01
    “…Applied to single-cell multi-omics data on type 2 diabetes and hair follicle development, regX reliably prioritizes key transcription factors and candidate cis-regulatory elements that drive cell state transitions. …”
    Get full text
    Article
  17. 1437

    The Role of Inflammation, Oxidative Stress, Neuronal Damage, and Endothelial Dysfunction in the Neuropathology of Cognitive Complications in Diabetes: A Moderation and Mediation An... by Betul Sumbul‐Sekerci, Ozge Pasin, Ezgi Balkan, Abdusselam Sekerci

    Published 2025-01-01
    “…Methods This study assessed 183 participants (54 prediabetes, 71 Type 2 diabetes mellitus [T2DM], and 58 controls) for cognitive performance using the Montreal Cognitive Assessment (MoCA). …”
    Get full text
    Article
  18. 1438

    Prevalence of Undiagnosed Diabetes and Prediabetes in the Dental Setting: A Systematic Review and Meta-Analysis by Alagesan Chinnasamy, Marjory Moodie

    Published 2020-01-01
    “…To make a reliable estimate on the prevalence of undiagnosed type 2 diabetes mellitus (T2DM) and prediabetes among dental patients in the dental setting and to assist healthcare planners in making an informed decision, information on the disease frequency and strategies employed to address this issue is of paramount importance. …”
    Get full text
    Article
  19. 1439

    Characteristics of the Relationship of Kidney Dysfunction with Cardiovascular Disease in High Risk Patients with Diabetes by Attilio Losito, Loretta Pittavini, Ivano Zampi, Elena Zampi

    Published 2016-01-01
    “…We aimed at comparing the relationship of reduced estimated glomerular filtration rate (eGFR) with cardiovascular disease (CVD) and mortality between high risk patients with and without type 2 diabetes mellitus (T2DM). The cross-sectional study evaluated 16,298 participants (1,627 T2DM) acutely admitted to hospital. …”
    Get full text
    Article
  20. 1440

    Recent Advances and Perspectives on the Use of Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Chronic Kidney Disease: A Review by Kisho Miyasako, Yujiro Maeoka, Takao Masaki

    Published 2024-12-01
    “…Furthermore, end-stage kidney disease severely affects life expectancy and quality of life. Type 2 diabetes and hypertension are not only primary causes of CKD but also independent risk factors for CVD, which underscores the importance of effective treatment strategies for these conditions. …”
    Get full text
    Article